Marco Lobba

Honestly, let me school you on Marco Lobba. This guy’s a straight-up science boss turned startup legend. He’s the co-founder and CEO of Catena Biosciences, a company all about pushing the limits of precision medicine with some advanced protein therapeutics. Basically, he’s out here trying to change how we fight diseases, making treatments way more targeted and smarter. No bullshit.

So, the backstory, Marco kicked things off with a solid biochemistry degree from Pomona College, not too shabby, right? But what really kicked him into high gear was his PhD from UC Berkeley, where he got to work in the labs of some big brains, Jennifer Doudna, the Nobel winner behind CRISPR, and Matthew Francis, a legend in chemistry. That’s some serious academic firepower. It shows he’s always been about pushing boundaries, messing around with gene editing, protein conjugation, and all that modern biotech stuff.

His expertise? Pure science magic, he’s a wizard at protein conjugation, which is basically attaching different molecules to proteins to create new treatments. Thanks to him, we’re talking about multi-payload conjugates, CRISPR editors, cell therapies, all the stuff that’s gonna make medicine way more personalized and works well. His work is rooted in chemistry, biology, and gene editing, which means he’s blending these fields to really shake up the healthcare game.

But here’s what’s dope, Marco didn’t just stay in the lab. He jumped into the startup scene, co-founding CatenaBio in S21 as part of YC’s batch, that’s the big leagues for early startups. That move? It proves he’s all about turning science into real-world impact. He’s got that entrepreneurial fire, ready to take his new research and actually bring it to people who need it.

What does all this tell us about him? The dude’s motivated by a real desire to change medicine. He’s not just doing science for the sake of it; he wants to make real impact. Starting a company like CatenaBio? That’s the ultimate grind, turning complex research into real-world solutions. He’s a perfect example of a scientist who’s not satisfied with just publishing papers but wants to change lives.

So, in a nutshell, Marco Lobba is a biotech pioneer, blending top-tier academic chops with a startup hustle to push the frontiers of precision medicine. He’s the real deal, someone who’s not afraid to jump into the deep end, disrupt the status quo, and make some serious waves.